BMC Infectious Diseases (Jul 2022)

SARS-CoV-2 reinfections in a US university setting, Fall 2020 to Spring 2021

  • Molly Rosenberg,
  • Chen Chen,
  • Lilian Golzarri-Arroyo,
  • Aaron Carroll,
  • Nir Menachemi,
  • Christina Ludema

DOI
https://doi.org/10.1186/s12879-022-07578-x
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Background SARS-CoV-2 reinfections are a public health concern because of the potential for transmission and clinical disease, and because of our limited understanding of whether and how well an infection confers protection against subsequent infections. Despite the public health importance, few studies have reported rigorous estimates of reinfection risk. Methods Leveraging Indiana University’s comprehensive testing program to identify both asymptomatic and symptomatic SARS-CoV-2 cases, we estimated the incidence of SARS-CoV-2 reinfection among students, faculty, and staff across the 2020–2021 academic year. We contextualized the reinfection data with information on key covariates: age, sex, Greek organization membership, student vs faculty/staff affiliation, and testing type. Results Among 12,272 people with primary infections, we found a low level of SARS-CoV-2 reinfections (0.6%; 0.4 per 10,000 person-days). We observed higher risk for SARS-CoV-2 reinfections in Greek-affiliated students. Conclusions We found evidence for low levels of SARS-CoV-2 reinfection in a large multi-campus university population during a time-period prior to widespread COVID-19 vaccination.

Keywords